Immediately after arriving in the blood, tumor cells activate platelets via the TF/thrombin pathway, resulting in the formation of a tight platelet cloak around the tumor cells, protecting them from shear stress and immune surveillance, e.g., detrimental NK cell assaults [14]. Here, TF is linked to neoplasm.